pillbase.ru

Strensiq

Active substance: asfotase alfa

asfotase alfa

Centralised EU authorisationActive

Marketing holder: Alexion Europe SAS

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • STRENSIQ
    SOLUTION · ASFOTASE ALFA 18 mg/.45mL
    25682-010
    Alexion Pharmaceuticals, Inc.
  • STRENSIQ
    SOLUTION · ASFOTASE ALFA 40 mg/mL
    25682-016
    Alexion Pharmaceuticals, Inc.
  • STRENSIQ
    SOLUTION · ASFOTASE ALFA 80 mg/.8mL
    25682-019
    Alexion Pharmaceuticals, Inc.
  • STRENSIQ
    SOLUTION · ASFOTASE ALFA 28 mg/.7mL
    25682-013
    Alexion Pharmaceuticals, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4dd3-7b4c-bffe-79ee208f8f9f,01a1208c-4dd5-71a2-9db3-c7c25bf06217,01a1208d-040b-7048-ab85-abc5185d5ef1,01a1209d-0b6d-7896-be79-7af572b58bee;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003794
Registration status
Active
ATC code
A16AB
Sources
  • product · EMA · EMEA/H/C/003794 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003794 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003794 · Verified 2026-10-09